Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Understand when to rebalance for tax efficiency in retirement. This guide covers timing signals and simple checks to keep your portfolio compliant and efficient.
17,298 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
A quiet, strategic move by Warren Buffett's Berkshire Hathaway placed a small bet on The New York Times. Here’s what ...
Hycroft Mining stock is catching momentum as the company reports stronger gold and silver resources and clearer plans...
Ripple’s XRP Ledger introduced a permissioned DEX and on-chain escrow tools aimed at banks and regulated firms, poten...
Investing in rare earths is a long game tied to U.S. policy, global demand, and the pace of production. This guide co...
Three well-known retailers face rising pressure as consumer spending cools and online competition intensifies. These ...
Friday brought a notable rally for Integer Holdings as earnings beat and optimistic analyst updates boosted sentiment...
A Friday Supreme Court ruling spurs new tariffs, forcing small business owners scramble to cope as costs rise and cas...
Tesla beat market expectations with stronger-than-forecast Q4 results, sending shares higher as investors weigh the c...
Today’s trading session spotlighted PayPal as takeover rumors circulated, lifting the stock while the broader market ...
A growing AI marketing platform is courting retail investors with a Reg A+ round at $0.85 per share, pitching a scala...
Investors are eyeing Life Time's Q4 2025 earnings to gauge membership momentum, pricing discipline, and growth strate...